Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

medicines bill

- PMLiVE

Clinigen launches ‘What is Possible?’ campaign on Rare Disease Day to accelerate access to medicines

There are over 7,000 rare diseases impacting more than 300 million people globally

EU cross-border healthcare

The clock is ticking to improve access to gene and cell therapies for rare diseases

- PMLiVE

Centre for Innovation in Regulatory Science awarded $1.09m Gates Foundation grant

Grant will help accelerate medicine registration in low/middle-income countries

- PMLiVE

NICE International relaunches, will offer advisory services

Meets growing demand from global health and social care organisations

- PMLiVE

Brexit contributes to surge in generic drug prices

Calls for government to protect pharmacies

Comment: the new UK pricing deal – welcome news, but lessons to be learned

Leslie Galloway, chairman of EMIG reflects on the new UK government-pharma industry pricing agreement

- PMLiVE

New ‘voluntary’ UK pricing deal caps growth, but promises faster uptake

Decades old PPRS name to go

- PMLiVE

UK unveils plans for bigger medicines price squeeze

Company payments to government would rise steeply to 2021

UK flag

UK appoints pharma veteran to ‘streamline’ NHS costs

Steve Oldfield will take up new chief commercial officer role at the Department of Health

UK flag

UK government tables bill on medicine pricing reforms

New scheme proposes single payment mechanism for old and new drugs alike

- PMLiVE

Pharma must ‘create new social contract’

New task force established in UK to assess public’s view of the value and risk of medicines

- PMLiVE

GSK found UK’s drug pricing changes a tough sell

Firm's chief executive met with the government to question the last PPRS update

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links